Monoamine oxidase molecular activity in platelets of parkinsonian and demented patients

Neurodegeneration

Volumn 5, Issue 4, 1996, Pages 351-357

  Bongioanni, R ^a   Mondino, C ^b   Boccardi, B ^a   Borgna, M ^a   Castagna, M ^a  

^a Sc Superiore di Studi Universitari   (Italy)

^b NONE

Author keywords

Dementia of Alzheimer type; Monoamine oxidase molecular activity; Neurodegenerative diseases; Parkinson's disease; Platelet monoamine oxidase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BIOCHEMICAL MARKER; THROMBOCYTE ENZYME;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; NERVE DEGENERATION; PARKINSONISM; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0030499315     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1006/neur.1996.0047     Document Type: Article

References (43)

1. Adolfsson R, Gottfries CG, Oreland L, Wiberg Å, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27:1029-1034
2. Alexopoulos GS, Lieberman KW, Young RC (1984) Platelet MAO activity in primary degenerative dementia. Am J Psychiatry 141:97-99
3. Ansari GAS, Patel NT, Fritz RR, Abell CW (1983) Purification of human platelet monoamine oxidase B by high performance liquid chromatography. J Liq Chromatogr 6:1407-1411
4. Belendiuk K, Belendiuk GW, Freedman DX, Antel IP (1981) Neurotransmitter abnormalities in patients with motor neuron disease. Arch Neurol 38:415-417
5. Belmaker RH, Ebbesen K, Ebstein R, Rimon R (1976) Platelet monoamine oxidase in schizophrenia and manic-depressive illness. Br J Psychiatry 129:227-232
6. Bongioanni P (1987) Platelet as a model in neurological studies: biochemical and clinical features. Arch Psicol Neurol Psichiat 48: 169-192
7. Bongioanni P (1988) Platelets as model in psychiatric studies. NPS 8:582-618
8. Bongioanni P, Rimonsson T, Donato M (1991a) Enhanced platelet monoamine oxidase activity as marker of degeneration in the central nervous system. Eur J Clin Invest 21:24
9. Bongioanni P, Rimonsson T, Donato M (1991b) Platelet monoamine oxidase molecular activity in Parkinsonian patients. In Proceedings of the European Conference on Parkinson's Disease and Extrapyramidal Disorders, Rome 1990. John Libbey CIC, Rome, Milan, London, pp 157-161
10. Checkoway H, Costa LG, Woods JS, Castoldi AF, Lund BO, Swanson PD (1992) Peripheral blood cell activities of monamine oxidase B and Superoxide dismutase in Parkinson's disease. J Neural Transm Park Dis Dement Sect 4:283-290
11. Craig IW, Powell JF, Brown GK, Summers KM (1982) Studies of human monoamine oxidase. In Kamijo K, Usdin E, Nagatsu T (eds) Monoamine oxidase: basic and clinical frontiers Excerpta Medica, Princeton, pp 18-32
12. Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G (1988) Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand 78:730-736
13. Denney RM, Patel NT, Fritz RR, Abell CW (1982) A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A. Mol Pharmacol 22:500-508
14. Denney RM, Fritz RR, Patel NT, Widen SG, Abell CW (1983) Use of monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues. Mol Pharmacol 24:60-67
15. Factor SA, Ortof E, Dentinger MP, Mankes R, Barron KD (1994) Platelet morphology in Parkinson's disease: an electron microscopic study. J Neurol Sci 122:84-89
16. Fahn S, Elton RL, Agid Y, Barbeau A et al. (1987) Unified Parkinson's disease rating scale. In Fahn S, Marsden CD, Calne DB, Goldstein M (eds) vol. II MacMillan Healthcare Information, New York pp 2-57
17. Fischer P, Gotz ME, Ellinger B, Streifler M, Riederer P, Danielczyk W (1994) Platelet monoamine oxidase B activity and vitamin B12 in dementia. Biol Psychiatry 35:772-774
18. Fritz RR, Abell CW (1982) Solubilization of monoamine oxidase by octylglucoside and Triton X-100. Biochem Med 28:94-97
19. Fritz RR, Abell CW, Denney RM, Denney CB, Bessman JD, Boeringa JA, Castellani S, Lankford DA, Malek-Ahmadi P, Rose RM (1986) Platelet MAO concentration and molecular activity I. New methods using a MAO B-specific monoclonal antibody in a radioimmunoassay. Psychiatry Res 17:129-140
20. Fritz RR, Malek-Ahmadi P, Rose RM, Denney RM, Abell CW (1983) Tranylcypromine lowers human platelet MAO B activity but not concentration. Biol Psychiatry 18:685-691
21. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
22. Hoehn MM, Yahr MD (1967) Parkinsonism onset, progression and mortality. Neurology 17:427-456
23. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiat 140:566-572
24. Jarman J, Glover V, Sandler M, Turjanski N, Stern G (1993) Platelet monoamine oxidase B activity in Parkinson' s disease: a reevaluation. J Neural Transm Park Dis Dement Sect 5:1-4
25. Kuiper MA, Konings CH, Bergmans PL, Wolters EC (1993) Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients. J Neurol Sci 117:41-45
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
27. Mann JJ, Chiu E (1978) Platelet monoamine oxidase activity in Huntington's chorea. J Neurol Neurosurg Psychiatry 41:809-812
28. Mann JJ, Stanley M, Kaplan RD, Sweeney J, Neophytides A (1983) Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. J Neurol Neurosurg Psychiatry 46:905-910
29. Oreland L, Gottfries CG (1986) Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Prog Neuropsychopharmacol Biol Psychiatry 10:533-540
30. Parnetti L, Reboldi GP, Santucci C, Santucci A, Brunetti M, Cecchetti R, Senin U (1994) Platelet MAO-B activity as a marker of behavioural characteristics in dementia disorders. Aging 6:201-207
31. Piccini P, Bongioanni P, Nuti A, Bonuccelli U, Pacifici GM, Muratorio A (1989) Attività monoamino-ossidasica nelle piastrine di parkinsoniani. In Proceedings of the XV Meeting of the Italian League against Parkinson's Disease and Extrapyramidal Disorders, Alba (CN) 1988. Guanella Editore, Rome, pp 99-108
32. Pletscher A (1978) Platelets as models for monoaminergic neurons. In Youdim MBH (ed) Essays in neurochemistry and neuropharmacology, vol 3. John Wiley & Sons, London, pp 49-101
33. Pletscher A (1988) Platelets as models: use and limitations. Experientia 44:152-155
34. Rose RM, Castellani S, Boeringa JA, Malek-Ahmadi P, Lankford DA, Bessman JD, Fritz RR, Denney CB, Denney RM, Abell CW (1986) Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations. Psychiatry Res 17:141-151
35. Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Löffler J, Richards JG (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neurosci 62:15-30
36. Smith RC, Ho BT, Kralik P, Vroulis MSG, Gordon J, Wolf J (1982) Platelet monoamine oxidase in Alzheimer's Disease. J Gerontol 37:572-574
37. Steventon GB, Sturman SG, Heafield MT, Waring RH, Napier J, Williams AC (1989) Platelet monoamine oxidase-B activity in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1:255-261
38. Wiberg Å, Oreland L (1976) Quantitative aspects of mitochondrial monoamine oxidase in human platelets. Med Biol 54:137-141
39. Williams A, Steventon G, Sturman S, Waring R (1991) Xenobiotic enzyme profiles and Parkinson's disease. Neurology 41(5S2):29-32
40. Youdim MBH (1988) Platelet monoamine oxidase B: use and misuse. Experientia 44:137-141
41. Yu PH, Boulton AA (1979) Activation of platelet monoamine oxidase by plasma in the human. Life Sci 25:31-37
42. Zeller EA, Boshes B, Arbit J, Bieber M, Blonsky ER, Dolkart M, Huprikar SV (1976) Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase. J Neural Transm 39:63-77
43. Zubenko GS, Wusylko M, Boller F, Teply I (1987) Family study of platelet membrane fluidity in Alzheimer's disease. Science 238: 539-542